Target signaling with material adverse change clauses in merger agreements

被引:6
|
作者
Macias, Antonio J. [1 ,3 ]
Moeller, Thomas [2 ,4 ]
机构
[1] Baylor Univ, Waco, TX 76798 USA
[2] Texas Christian Univ, Ft Worth, TX 76129 USA
[3] One Bear Pl 98004, Waco, TX 76798 USA
[4] TCU Box 298530, Ft Worth, TX 76129 USA
关键词
Mergers; Acquisitions; Signaling; Material adverse change clauses; INFORMATION ASYMMETRY; CONTRACTS; RENEGOTIATION; DIVERSIFICATION; VALUATION; DESIGN; FIRMS;
D O I
10.1016/j.jempfin.2016.09.002
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Material Adverse Change (MAC) clauses play key roles in essentially all merger negotiations. Fewer exclusions in MAC clauses imply broader abandonment options for acquirers. We study the motivation for different scopes of acquirers' abandonment options. In our comprehensive hand-collected sample, broader firm-specific abandonment options are associated with higher target announcement returns and higher combined acquirer and target announcement gains, lower probabilities of MAC occurrences, and lower conditional completion rates when MACs occur. They are also more prevalent in higher-quality firms with larger information asymmetries. Overall, the results indicate that targets' credibly signaling their higher values or greater synergies is one motivation for broader abandonment options for acquirers.
引用
收藏
页码:69 / 92
页数:24
相关论文
共 18 条
  • [11] Navigating trans-atlantic deals: warranties, disclosure and material adverse change
    Phillips, John
    Runnicles, Julian
    Schwartz, Jeffery
    JOURNAL OF FINANCIAL REGULATION AND COMPLIANCE, 2007, 15 (04) : 472 - 481
  • [12] BACKSCATTERED ELECTRONS IN THE SEM - THE CONTRAST DUE TO THE CHANGE OF THE TARGET MATERIAL DENSITY
    CALSTYAN, VG
    AKCHURIN, MS
    IZVESTIYA AKADEMII NAUK SERIYA FIZICHESKAYA, 1993, 57 (08): : 59 - 61
  • [13] ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia
    Zhou, Chang
    Yang, Lu
    Zhao, Kai
    Jiang, Libo
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (06) : 3062 - 3074
  • [14] Lack of VEGFA/KDR Signaling in Conventional Renal Cell Carcinoma Explains the Low Efficacy of Target Therapy and Frequent Adverse Events
    Peterfi, Lehel
    Yusenko, Maria V.
    Kovacs, Gyula
    Beothe, Tamas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [15] Takeovers and public securities SOME SALUTARY LESSONS FROM THE PANEL ON KEEPING "A SAFE DISTANCE BETWEEN FRIENDS" AND ON" MATERIAL ADVERSE CHANGE" CONDITIONS
    Colla, Alberto
    COMPANY AND SECURITIES LAW JOURNAL, 2011, 29 (01): : 46 - 55
  • [16] Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation
    Bruserud, Oystein
    Reikvam, Hakon
    Fredly, Hanne
    Skavland, Jorn
    Hagen, Karen-Marie
    Tuyen Thy Van Hoang
    Brenner, Annette K.
    Kadi, Amir
    Astori, Audrey
    Gjertsen, Bjorn Tore
    Pendino, Frederic
    ONCOTARGET, 2015, 6 (05) : 2794 - 2811
  • [17] A phase change material selection using the interval-valued target-based BWM-CoCoMULTIMOORA approach: A case-study on interior building applications
    Maghsoodi, Abtin Ijadi
    Soudian, Shahrzad
    Martinez, Luis
    Herrera-Viedma, Enrique
    Zavadskas, Edmundas Kazimieras
    APPLIED SOFT COMPUTING, 2020, 95 (95)
  • [18] miR-425-5p promoting colorectal carcinoma progression by regulating its target gene PTEN to change activity of the PI3K/AKT/mTOR signaling pathway
    Zhao, Yijiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (01): : 144 - 153